Home/Free tools
Free Research Calculators and Assessment Tools
Access free calculators and checkers to support research planning, statistical analysis, manuscript preparation and publication decisions. Tools include a sample size calculator, effect-size converter, statistical test selector, reporting-guideline finder, systematic review screening estimator, predatory journal risk checker and grant eligibility checker.
Each tool displays the formula, reference or assessment criteria used, helping users understand and interpret the results. Tools run in your browser, with no registration, email address or file upload required.
Each tool has its own page, with the method and sources shown alongside the result.
- Runs in your browser
- Nothing uploaded or stored
- No email asked for
- Method shown with the answer
- Sources dated
Our Tools
Explore Our Free Research Tools
Five tools perform statistical calculations, four select or look up a published rule or guideline, and three estimate workload, timelines or journal risk. Select a tool to open its dedicated page.
Limitations
What These Tools Do Not Cover
A free tool that overstates its reach costs the person using it more than it saves. Here is where each kind of tool on this page stops.
The calculators
Limitations of the calculators
The sample size calculator gives the closed-form answer for two independent groups. Cluster randomisation, interim analyses, a non-inferiority margin, repeated measures and competing risks each change the number materially, and none of them can be handled by inflating the answer afterwards. The same applies to the test chooser: it cannot know that your observations are clustered within clinics, and clustering overrides almost everything else it would tell you.
The lookups
Limitations of the guideline and funder lookups
Reporting guidelines and funder rules move without much warning — CONSORT and SPIRIT both changed in 2025, TRIPOD in 2024, and two ERC career windows widened for the 2027 calls. Each of those tools carries the date its sources were last read and names them. Check the EQUATOR Network or the call text before you rely on it, and check the journal’s own instructions too, because they sometimes still name a retired version.
The estimators
Limitations of the estimators
The screening estimator counts reviewer hours, not elapsed time: it cannot know that your library does not hold forty of the full texts, or that an author will take three weeks to answer. The timeline planner leaves out ethics committee meeting cycles, which can add six weeks on their own. Both are deliberately built to be argued with — every rate in them is an editable field rather than a constant.
And none of them replaces the judgement they sit next to. A sample size calculator cannot tell you whether the effect you entered is clinically worth detecting, which is the question a reviewer will actually ask. What these tools do is make the shape of a problem visible while the design can still change, which is usually worth more than the calculation.
Method
Methods and Sources
Each tool names its source in the result panel. The main methods and references are listed below.
Sample size
Closed form
Normal-approximation formulas for two means and two proportions, with the pooled variance under the null; Schoenfeld’s requirement for the log-rank test. The inverse normal is Acklam’s rational approximation, accurate to about one part in 10⁹.
Effect sizes
Hedges, Hasselblad
Hedges’ small-sample correction for g; the Hasselblad–Hedges transform between d and the log odds ratio; the standard error of d from the two group sizes. Interval limits are converted through the same monotone transforms as the estimate.
Meta-analysis
DerSimonian–Laird
Inverse-variance weights, Cochran’s Q referred to a χ² distribution on k−1 degrees of freedom, and the DerSimonian–Laird estimator of τ². Ratio measures are pooled on the log scale and exponentiated back.
Risk and NNT
Altman
Katz’s log method for the risk-ratio interval, Woolf’s for the odds ratio, and Altman’s convention for reporting a number-needed-to-treat interval that crosses no difference as benefit to infinity to harm.
Reporting guidelines
Read September 2026
Each entry was checked against the guideline’s own publication or its EQUATOR Network record, including the two changes most likely to catch an author out: TRIPOD+AI replacing TRIPOD 2015, and CONSORT 2025 not covering AI interventions.
Funder rules
Read September 2026
The ERC Work Programme 2027, the Horizon Europe general annexes for 2026–27, the NIH Early Stage Investigator policy and Parent R01 notice, Wellcome’s scheme pages, and the ICMR extramural research guidelines.
Related Services
Research and Publication Services
When your project needs specialist input, Pubrica provides the following services.
1BEFORE THE STUDYwhen the number still changes something
Biostatistics and statistical programmingThe sample size defended in writing, the analysis plan, and the code that will run it. Experimental designThe design the calculator assumed you had, checked against the question you are asking.2DURING THE REVIEWwhen the screening estimate turns real
Systematic reviewRegistered protocol, dual screening, extraction and risk of bias, done to the standard. Meta-analysisWhether these studies should be pooled at all, and what to do when I² says they should not.FAQs
Ten questions about these tools.
Disagree with an answer one of them gave, or need a calculation we have not built? Ask an expert — no quote required.
They are free, and there is no catch to find. Nothing here asks for an email address, nothing is held back until you book a call, and no result is watermarked or truncated. They run entirely in your browser: what you type into the sample size calculator or paste into the heterogeneity calculator is never sent to us, because there is nowhere for it to be sent. We built them for our own statisticians, editors and medical writers, and the reason they are open is straightforward — a researcher who can check our arithmetic is a better client than one who cannot.
No. Every tool on this page is JavaScript running on your own machine. There is no server call, no analytics event carrying your inputs, no local storage and no file upload anywhere in any of the twelve. You can confirm that by opening your browser’s network tab while you use one, or by saving the page and running it with your connection off. For anything involving patient-level or commercially confidential data that is the only guarantee worth having, and it is the reason these were built this way.
Cite the method, not the tool. Every result panel names the formula or the published source it used — Schoenfeld for the log-rank event requirement, DerSimonian and Laird for τ², Altman and Bland for recovering a confidence interval from a p-value — and that primary reference is what belongs in your methods. If a reviewer asks how a number was produced, the panel gives you enough to reproduce it in R or by hand, which is the standard any calculation in a paper should meet.
The arithmetic is exact to the formula, and we check it against independent implementations before it ships. What limits it is the formula, not the code: these are the standard closed-form answers for two independent groups, and they do not cover cluster randomisation, interim analyses, non-inferiority margins, repeated measures, competing risks or multiple primary outcomes. Each of those changes the number materially, and none of them can be fixed by inflating the answer afterwards. If your design has one of them, the calculator will give you a number that is precisely wrong — use it to scope the conversation, then have the calculation done properly.
The reporting-guideline finder answers that for seventeen designs, and it carries two warnings worth knowing even if you never open it. TRIPOD 2015 has been replaced by TRIPOD+AI, which applies to regression models as well as machine-learning ones, so citing the 2015 statement is now out of date. And CONSORT 2025, which supersedes CONSORT 2010, does not cover trials of AI interventions — those still need the 2020 CONSORT-AI extension, which is written against the older checklist. Both are places where a confident wrong answer would cost an author a revision round.
It checks the criteria that can be checked mechanically — a career window, a host country, a consortium composition — and shows you the published rule beside the verdict so you can see what it is working from. It cannot assess a track record, and it does not know what a specific call has derogated. Three of the rules in it moved during 2026: both ERC career windows widened for the 2027 calls, NIH restructured how international collaborations are funded, and Wellcome’s geographic eligibility narrows on 29 October 2026. We date the tool for that reason. Treat it as a first filter, then read the call text before committing six weeks to writing.
No, and it would be dishonest to imply otherwise. A sample size calculator cannot tell you whether the effect you entered is clinically worth detecting, which is the part a reviewer actually challenges. A test chooser cannot see that your observations are clustered within clinics. The heterogeneity calculator will report I² for five studies that should never have been pooled. What these tools do well is make the size and shape of a problem visible early, while the design can still change — and that is usually worth more than the calculation itself.
Yes. Several of these started as internal calculators for a client project — a screening estimator built to scope a review for a hospital library, a timeline planner built for a research office that kept missing its own deadlines. If your department needs a version with your own rates, your own thresholds, or your institution’s branding and workflow behind it, that is a piece of work we take on. So is the reverse: auditing a calculator you already use, because a spreadsheet that has been passed between three postdocs is a common source of the error nobody can find.
Tell us, with the inputs you used. Every tool states its method precisely so that disagreements are resolvable rather than a matter of opinion, and we would rather hear about an error than have it sit there. If you are right, we fix it and say so on the page. If the disagreement turns out to be about which formula is appropriate for your design — which is the more common outcome — that is a more interesting conversation, and one worth having before the analysis rather than after review.
Yes, and the ones that get built are the ones researchers actually ask for. The twelve here came from questions that kept arriving: how many participants, which test, which checklist, how long will screening take, is this journal real, does the date hold. If there is a calculation you do repeatedly by hand or in a spreadsheet you no longer trust, tell us what it is. It is a short walk from a recurring question to a tool that answers it for everybody.
Discuss Your Project
Send us your study design, search, manuscript or deadline. A subject specialist will review it and provide a quote within two business days, at no cost and with no obligation.